Showing results (421-430 of 435) with videos related to
Sort By:
Pageof 44
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 20, 2001
Frequent inactivation of the TP53 gene in esophageal squamous cell carcinoma from a high-risk population in ChinaN Hu, J Huang, M R Emmert-Buck, et al.Cancer Detection and Prevention|April 3, 2003
Common genetic variants of TP53 and BRCA2 in esophageal cancer patients and healthy individuals from low and high risk areas of northern ChinaNan Hu, Wen-Jun Li, Hua Su, et al.Journal of the National Cancer Institute|May 3, 2001
Serum hormones and the alcohol-breast cancer association in postmenopausal womenJ F Dorgan, D J Baer, P S Albert, et al.British Journal of Cancer|April 1, 2004
Epidemiologic features of upper gastrointestinal tract cancers in Northeastern IranF Islami, F Kamangar, K Aghcheli, et al.Journal of Medical Genetics|October 26, 2007
Polymorphic MLH1 and risk of cancer after methylating chemotherapy for Hodgkin lymphomaL J Worrillow, A G Smith, K Scott, et al.Cancer Research|December 5, 2000
Loss of annexin 1 correlates with early onset of tumorigenesis in esophageal and prostate carcinomaC P Paweletz, D K Ornstein, M J Roth, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 9, 2020
Measures of body fatness and height in early and mid-to-late adulthood and prostate cancer: risk and mortality in The Pooling Project of Prospective Studies of Diet and CancerJ M Genkinger, K Wu, M Wang, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 18, 2014
Dairy products and pancreatic cancer risk: a pooled analysis of 14 cohort studiesJ M Genkinger, M Wang, R Li, et al.European Journal of Cancer (Oxford, England : 1990)|July 1, 1997
CHOP-based chemotherapy is as effective as alternating PEEC/CHOP chemotherapy in a randomised trial in high-grade non-Hodgkin's lymphoma. Scotland and Newcastle Lymphoma GroupD A Cameron, J M White, S J Proctor, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 12, 2019
Timing of HPV16-E6 antibody seroconversion before OPSCC: findings from the HPVC3 consortiumA R Kreimer, A Ferreiro-Iglesias, M Nygard, et al.Pageof 44